Utilizing the integrated difference of two survival functions to quantify the treatment contrast for designing, monitoring, and analyzing a comparative clinical study.
about
Meta-analysis of time-to-event outcomes from randomized trials using restricted mean survival time: application to individual participant data.Evaluating surrogate marker information using censored data.Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis.A predictive enrichment procedure to identify potential responders to a new therapy for randomized, comparative controlled clinical studiesDetection and prognostic value of pulmonary congestion by lung ultrasound in ambulatory heart failure patientsPredicting the restricted mean event time with the subject's baseline covariates in survival analysis.Assessment of the Risk of Hospitalization for Heart Failure With Dipeptidyl Peptidase-4 Inhibitors, Saxagliptin, Alogliptin, and Sitagliptin in Patients With Type 2 Diabetes, Using an Alternative Measure to the Hazard Ratio.Predicting Mean Survival Time from Reported Median Survival Time for Cancer Patients.On the restricted mean survival time curve in survival analysisA versatile test for equality of two survival functions based on weighted differences of Kaplan-Meier curves.Alternatives to Hazard Ratios for Comparing the Efficacy or Safety of Therapies in Noninferiority Studies.Efficiency of two sample tests via the restricted mean survival time for analyzing event time observations.Analysis of restricted mean survival time for length-biased data.Innovative methods for the identification of predictive biomarker signatures in oncology: Application to bevacizumab.
P2860
Q30976026-ADB74A4F-AD53-4B94-8B47-896374C34BDBQ31154746-441D304E-FCB5-4638-9337-BB7D74D8807DQ33928010-6CECB39F-EE99-42D1-B5B7-F9DB8C73B932Q37026562-9B8BEEC5-7F1E-4532-BA32-500B69A53B74Q37220202-014F9ED1-8371-4F17-81F8-ECE88F6C4E85Q37621905-45EDA176-618F-4C9B-BA7E-E806695C43D2Q38722045-3D935293-BC6C-47CC-9F8F-1D1A279C3A8FQ39647659-32096B7B-418B-4F15-B905-4D94B7B3C23AQ40612925-E8C2ABA2-DD62-4AF3-AE13-ADAB0BF285E7Q40714930-1013DFC3-9C8F-44DA-96E9-49F4E4B086F3Q40858704-6FF572FF-4640-4497-8D6D-DF128440BEA0Q46710975-AD2B9422-97C9-4060-AF93-A2C954F28351Q47693886-160CB61A-8FE7-49B6-A563-1A7A39D799F8Q55005400-11D8B6DE-5A39-4CF4-952E-66E5D6743201
P2860
Utilizing the integrated difference of two survival functions to quantify the treatment contrast for designing, monitoring, and analyzing a comparative clinical study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Utilizing the integrated diffe ...... a comparative clinical study.
@en
type
label
Utilizing the integrated diffe ...... a comparative clinical study.
@en
prefLabel
Utilizing the integrated diffe ...... a comparative clinical study.
@en
P2093
P2860
P356
P1433
P1476
Utilizing the integrated diffe ...... a comparative clinical study.
@en
P2093
Hajime Uno
Jerald S Schindler
Lee Jen Wei
Lihui Zhao
Marc A Pfeffer
Scott D Solomon
P2860
P304
P356
10.1177/1740774512455464
P577
2012-08-22T00:00:00Z